SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Thorsten Hornung, Joerg Wenzel, Innate Immune-Response Mechanisms in Dermatomyositis: An Update on Pathogenesis, Diagnosis and Treatment, Drugs, 2014, 74, 9, 981

    CrossRef

  2. 2
    Adam Huber, Brian M. Feldman, An update on inflammatory myositis in children, Current Opinion in Rheumatology, 2013, 25, 5, 630

    CrossRef

  3. 3
    Alisa N. Femia, Ruth Ann Vleugels, Jeffrey P. Callen, Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations, American Journal of Clinical Dermatology, 2013, 14, 4, 291

    CrossRef

  4. 4
    B. Bader-Meunier, C. Bodemer, Lupus sistémico y dermatomiositis infantil, EMC - Pediatría, 2013, 48, 4, 1

    CrossRef

  5. 5
    B. Bader-Meunier, C. Bodemer, Lupus systémique et dermatomyosites de l’enfant, EMC - Pédiatrie - Maladies infectieuses, 2013, 8, 2, 1

    CrossRef

  6. 6
    Heather J. Downing, Munir Pirmohamed, Michael W. Beresford, Rosalind L. Smyth, Paediatric use of mycophenolate mofetil, British Journal of Clinical Pharmacology, 2013, 75, 1
  7. 7
    Alisa Femia, Ruth Ann Vleugels, Pediatric Autoimmune Connective Tissue Diseases: An Update on Disease Characteristics, Associations, and Management, Current Dermatology Reports, 2013, 2, 4, 216

    CrossRef

  8. 8
    Andrea Baratta, Diana Camarillo, Christine Papa, James R. Treat, Aimee S. Payne, Suzanne S. Rozenber, Albert C. Yan, Pediatric Pemphigus Vulgaris: Durable Treatment Responses Achieved with Prednisone and Mycophenolate Mofetil (MMF), Pediatric Dermatology, 2013, 30, 2
  9. 9
    Ronald M. Laxer, Susanne M. Benseler, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  10. 10
    Marinka Twilt, Brian M Feldman, An update on the diagnosis and management of juvenile dermatomyositis, International Journal of Clinical Rheumatology, 2012, 7, 3, 325

    CrossRef

  11. 11
    Christina Lam, Ruth Ann Vleugels, Management of cutaneous dermatomyositis, Dermatologic Therapy, 2012, 25, 2
  12. 12
    Chikara Ogimi, Nazuna Honma, Risa Tanaka, Tsutomu Oh-ishi, Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura, Modern Rheumatology, 2012, 22, 2, 280

    CrossRef

  13. 13
    Chikara Ogimi, Nazuna Honma, Risa Tanaka, Tsutomu Oh-ishi, Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura, Modern Rheumatology, 2012, 22, 2, 280

    CrossRef

  14. 14
    Lisa C. Zaba, David F. Fiorentino, Skin disease in dermatomyositis, Current Opinion in Rheumatology, 2012, 24, 6, 597

    CrossRef

  15. 15
    Rohit Aggarwal, Chester V. Oddis, Therapeutic advances in myositis, Current Opinion in Rheumatology, 2012, 24, 6, 635

    CrossRef

  16. 16
    Tammy M. Martin, James T. Rosenbaum, An Update on the Genetics of HLA B27-associated Acute Anterior Uveitis, Ocular Immunology and Inflammation, 2011, 19, 2, 108

    CrossRef

  17. 17
    Angela B. Robinson, Ann M. Reed, Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis, Nature Reviews Rheumatology, 2011, 7, 11, 664

    CrossRef

  18. 18
    Heřman F. Mann, Jiří Vencovský, Clinical trials roundup in idiopathic inflammatory myopathies, Current Opinion in Rheumatology, 2011, 23, 6, 605

    CrossRef

  19. 19
    Lisa G. Rider, Victoria P. Werth, Adam M. Huber, Helene Alexanderson, Anand Prahalad Rao, Nicolino Ruperto, Laura Herbelin, Richard Barohn, David Isenberg, Frederick W. Miller, Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI), Arthritis Care & Research, 2011, 63, S11
  20. 20
    Rohit Aggarwal, Chester V. Oddis, Therapeutic Approaches in Myositis, Current Rheumatology Reports, 2011, 13, 3, 182

    CrossRef

  21. 21
    Paul Golumbek, Pharmacologic Agents for Pediatric Neuroimmune Disorders, Seminars in Pediatric Neurology, 2010, 17, 4, 245

    CrossRef